相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice
Joshua D. Bernstock et al.
CANCER GENE THERAPY (2020)
The two-faces of NK cells in oncolytic virotherapy
M. Marotel et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
Mark W. Kieran et al.
NEURO-ONCOLOGY (2019)
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis
Cassie Kline et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay et al.
CANCER CELL (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Gregory K. Friedman et al.
SCIENTIFIC REPORTS (2018)
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Paul M. Foreman et al.
NEUROTHERAPEUTICS (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+and CD15+cells are sensitive to killing by oncolytic herpes simplex viruses
Gregory K. Friedman et al.
NEURO-ONCOLOGY (2016)
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma
Fernando Carceller et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy
Kristian Taipale et al.
MOLECULAR THERAPY (2016)
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study
Regina I. Jakacki et al.
NEURO-ONCOLOGY (2016)
Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study
Howard L. Kaufman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
Jennifer L. Leddon et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
S. J. Advani et al.
GENE THERAPY (2011)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Engineered herpes simplex viruses efficiently infect and kill CD133+human glioma xenograft cells that express CD111
Gregory K. Friedman et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
Fabian Benencia et al.
CANCER BIOLOGY & THERAPY (2008)
Seroprevalence of herpes simplex virus type 1 in children in the united states
Fujie Xu et al.
JOURNAL OF PEDIATRICS (2007)
Dcvelopment and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection
A Lang et al.
JOURNAL OF IMMUNOLOGY (2005)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
分享论文
